Yasuo Nagafuchi Selected Research

Yasuo Nagafuchi Research Topics

Disease

11	Rheumatoid Arthritis 02/2022 - 07/2013
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2017
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2021 - 10/2019
2	Proteinuria 07/2022 - 01/2020
2	Inflammation (Inflammations) 07/2022 - 01/2017
2	Systemic Scleroderma (Systemic Sclerosis) 08/2021 - 01/2021
2	Obesity 02/2021 - 01/2017
1	Amyloidosis 07/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2022
1	Ossification of the posterior longitudinal ligament of the spine 02/2022
1	Osteoarthritis 02/2022
1	Hearing Loss (Hearing Impairment) 02/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Giant Cell Arteritis (Horton Disease) 01/2022
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 08/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Lupus Nephritis 01/2020
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Polyarteritis Nodosa (Periarteritis Nodosa) 07/2017
1	Overweight 01/2017
1	Experimental Arthritis 05/2015
1	Arthritis (Polyarthritis) 05/2015
1	Latent Tuberculosis 09/2013
1	Cough 09/2013
1	Necrosis 09/2013
1	Chest Pain (Chest Pains) 09/2013
1	Pleural Tuberculosis 09/2013
1	Granuloma 09/2013
1	Fever (Fevers) 09/2013

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 01/2022 - 07/2017
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 08/2021 - 01/2021
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018 - 01/2016
2	EpitopesIBA 01/2018 - 05/2015
1	canakinumab FDA Link 07/2022
1	Collagen Type XIIBA 02/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022
1	Inosine Triphosphate (ITP)IBA 10/2021
1	VA 061 (VA061)IBA 10/2021
1	AmphiregulinIBA 08/2021
1	Epidermal Growth Factor (EGF)IBA 08/2021
1	Heparin (Liquaemin)FDA LinkGeneric 08/2021
1	EGF Family of ProteinsIBA 08/2021
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 08/2021
1	AdipokinesIBA 02/2021
1	AdiponectinIBA 02/2021
1	LeptinIBA 02/2021
1	Vitamin D FDA LinkGeneric 02/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2020
1	Protein-Arginine DeiminasesIBA 01/2020
1	anti-dsDNA autoantibodyIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 07/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2017
1	interleukin-21 (interleukin 21)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	InterleukinsIBA 01/2017
1	Abatacept (Orencia)FDA Link 01/2017
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2017
1	Peptides (Polypeptides)IBA 05/2015
1	Interleukin-10 (Interleukin 10)IBA 05/2015
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 05/2015
1	AutoantigensIBA 05/2015
1	Benzophenoneidum (Auramine O)IBA 09/2013
1	Adalimumab (Humira)FDA Link 09/2013
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2013

Therapy/Procedure

1	Precision Medicine 10/2019
1	Therapeutics 07/2017
1	Oral Administration 05/2015
1	Aftercare (After-Treatment) 09/2013